Evidence map›Paper›PMID 40611685›Full record

ArticleEuropean journal of translational myology2025

Is a multidimensional robotic rehabilitation approach feasible in Guillain-Barrè syndrome? Report from a clinical case.

Caterina Tramonti, Benedetta Gnetti, Paola Gemignani, Stefania Callegari, Marco Germanotta, Francesca Cecchi, Irene Giovanna Aprile, Pietro Balbi

Abstract read
In one paragraph

Article in European journal of translational myology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Caterina TramontiIRCCS Fondazione Don Carlo Gnocchi, Firenze.
Benedetta GnettiIRCCS Fondazione Don Carlo Gnocchi, Firenze.ORCID 0009-0002-7687-0187
Paola GemignaniIRCCS Fondazione Don Carlo Gnocchi, Firenze.
Stefania CallegariIRCCS Fondazione Don Carlo Gnocchi, Firenze.
Marco GermanottaIRCCS Fondazione Don Carlo Gnocchi, Firenze.ORCID 0000-0002-0747-831X
Francesca CecchiIRCCS Fondazione Don Carlo Gnocchi, Firenze, Italy; Department of Experimental and Clinical Medicine, University of Florence.ORCID 0000-0002-7410-0325
Irene Giovanna AprileIRCCS Fondazione Don Carlo Gnocchi, Firenze.ORCID 0000-0001-8123-9977
Pietro BalbiIRCCS Fondazione Don Carlo Gnocchi, Firenze.ORCID 0000-0003-0456-2978

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the case of a 54-year-old patient, who was admitted to our Rehabilitation Unit with diagnosis of Guillain-Barré Syndrome (GBS). Neurophysiological investigation revealed an axonal polyneuropathy, with impairment of the motor component and preserved sensory function. Despite rapid diagnosis, therapeutic treatment and customized progressive rehabilitation program, nine months after the onset of the disease he presented severe motor sequelae and functional impairment. Patient's hospitalization lasted about two months, while he performed a conventional rehabilitation training. Besides, he underwent a 4-week comprehensive rehabilitation treatment, including both conventional and robotic multidimensional trainings, for 5 1-h sessions per week. Despite the residual global impairment, this treatment, specifically tailored on patient's skills and progress, promoted improvements in functional abilities such as motricity, trunk control, and activities of daily living. Therefore, this case report evidenced the feasibility and efficacy of a multidimensional robotic therapeutic approach along with conventional treatment in the post-acute phase of GBS.

Identifiers

PMID40611685
PMCPMC12536679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.